# Moderna, Inc.: Form 8-K, filed May 9, 2024

- Company: [Moderna, Inc.](/companies/mrna.md) (CIK 1682852)
- Form: 8-K
- Filed: 2024-05-09
- Accepted by EDGAR: May 8, 2024, 17:58 ET
- Period: 2024-05-06
- Accession: 0001682852-24-000031
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000031/mrna-20240506.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1682852/000168285224000031/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1682852/000168285224000031/mrna-20240506.htm

Filed May 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001682852-24-000031. Last ingested by Listed: Nov 10, 2026, 03:22 ET. No prices; not investment advice.